Borrelia miyamotoi is an emerging tick-borne pathogen in the Northern Hemisphere and is
the causative agent of Borrelia miyamotoi disease (BMD). Borrelia miyamotoi is vectored by …

Infectious diseases, caused by various pathogens in the clinic, threaten the safety of human
life, are harmful to physical and mental health, and also increase economic burdens on …

Serodiagnosis of SARS-CoV-2 infection is impeded by immunological cross-reactivity
among the human coronaviruses (HCoVs): SARS-CoV-2, SARS-CoV-1, MERS-CoV, OC43 …

Borrelia burgdorferi, the agent of Lyme disease, is estimated to cause> 400,000 annual
infections in the United States. Serology is the primary laboratory method to support the …

Fungi of the Paracoccidioides genus are the etiological agents of paracoccidioidomycosis
(PCM), a systemic mycosis restricted to the countries of Latin America. Currently, the …

Current serological tests for the emerging tick-borne pathogen Borrelia miyamotoi lack
diagnostic accuracy. To improve serodiagnosis, we investigated a protein array …

ABSTRACT A modified two-tiered testing algorithm (MTTT; ZEUS Scientific) for Borrelia
burgdorferi was recently FDA-cleared. We evaluated the MTTT algorithm to confirm Lyme …

Co-infections are a poorly understood aspect of tick-borne diseases. In the United States
alone, nineteen different tick-borne pathogens have been identified. The majority of these …

Peptide microarrays have emerged as a powerful technology in immunoproteomics as they
provide a tool to measure the abundance of different antibodies in patient serum samples …

The impact of the emerging tick-borne pathogen Borrelia miyamotoi is not fully understood.
We utilised a protein array to investigate B. miyamotoi seroreactivity in various human …